Complete Filing Data
Uxin Ltd reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $3.55 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Uxin Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$372.4M | -$137.2M | -$143.2M | -$421.2M | -$1.99B | -$1.52B | -$2.72B | -$1.36B |
| Revenue From Contract With Customer Excluding Assessed Tax | $1.37B | $2.06B | $1.64B | $657.4M | $1.59B | $659.1M | $309.1M | $824.5M |
| Operating Income Loss | -$312.5M | -$356.9M | -$278.9M | -$552.6M | -$1.29B | -$2.49B | -$388.2M | -$1.25B |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$375.3M | -$147.1M | -$143.3M | -$732.6M | -$1.36B | -$1.35B | -$1.27B | -$1.38B |
| Cost Of Revenue | $1.29B | $2.03B | $1.59B | $673.7M | $689.3M | $418.9M | $92.7M | $533.4M |
| Net Income Loss Available To Common Stockholders Basic | -$2.43B | -$892.8M | -$143.2M | -$421.2M | -$1.99B | -$2.39B | -$3.77B | -$1.78B |
| Gross Profit | $80.6M | $25.4M | $47.7M | -$16.3M | $898.7M | $240.2M | $216.4M | $291.1M |
| Selling And Marketing Expense | $202.5M | $236.3M | $222.1M | $339.0M | $1.18B | $1.49B | $179.3M | $793.5M |
| Other Nonoperating Expense | $5.9M | $24.2M | $8.9M | $7.9M | $36.6M | $25.6M | $3.8M | $16.1M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $4.9M | -$68.3M | $70.7M | $111.0M | -$18.0M | $4.8M | $43.4M | -$3.3M |
| Income Taxes Paid Net | $288.0K | $222.0K | $179.0K | $22.0K | $7.8M | $4.6M | $6.4M | $261.0K |
| General And Administrative Expense | $177.4M | $164.5M | $151.0M | $277.9M | $402.0M | $1.07B | $389.1M | $583.7M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$364.6M | -$205.4M | -$72.5M | -$310.2M | -$2.01B | -$1.53B | -$2.70B | -$1.40B |
| Comprehensive Income Net Of Tax | -$367.5M | -$205.4M | -$72.5M | -$310.2M | -$2.01B | -$1.51B | -$2.68B | -$1.36B |
| Operating Expenses | $411.1M | $452.4M | $408.7M | $782.7M | $2.19B | $2.73B | $604.6M | $1.54B |
| Income Tax Expense Benefit | $311.0K | $366.0K | $245.0K | $33.0K | -$2.6M | $1.6M | $211.0K | $1.8M |
| Income Loss From Equity Method Investments | -$6.0M | -$44.0K | $328.0K | $15.7M | $30.2M | $2.6M | $3.6M | -$9.6M |
| Research And Development Expense | $33.8M | $37.7M | $36.2M | $74.1M | $140.0M | $124.5M | $226.0M | $167.8M |
| Amortization Of Intangible Assets | $28.6M | $17.5M | $27.0K | $111.0K | $6.9M | $5.6M | $3.7M | $3.2M |
| Other Nonoperating Income | $15.9M | $17.1M | $5.2M | $15.7M | $71.1M | $23.7M | $4.2M | |
| Interest Expense | $62.6M | $21.2M | $41.2M | $96.0M | $112.6M | $63.9M | $199.0K | |
| Net Income Loss Attributable To Noncontrolling Interest | $394.0K | -$12.0K | -$9.0K | -$1.5M | -$15.8M | -$25.2M | -$35.2M | |
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$20.0M | -$143.2M | -$717.0M | -$1.33B | -$1.35B | -$1.27B | ||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $2.8M | -$12.0K | -$9.0K | -$1.6M | -$22.4M | -$27.9M | -$31.4M | |
| Net Income Loss From Continuing Operations Available To Common Shareholders Basic | -$130.0M | -$143.2M | -$717.0M | -$1.33B | -$2.20B | -$2.29B | ||
| Income Loss From Continuing Operations Per Diluted Share | -$0.10 | -$2.07 | -$0.65 | -$1.50 | -$4.60 | -$46.52 | ||
| Income Loss From Continuing Operations Per Basic Share | -$0.10 | -$0.12 | -$0.65 | -$1.50 | -$4.60 | -$46.52 | ||
| Income Loss From Continuing Operations | -$130.0M | -$143.2M | -$717.0M | -$1.33B | -$1.34B | -$1.24B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Net Income * | -$2.48B | -$285.0M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $103.9M | $335.8M | |
| Operating Income Loss | -$2.19B | -$295.0M | |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$2.04B | -$299.9M | |
| Cost Of Revenue | $110.7M | $156.4M | |
| Net Income Loss Available To Common Stockholders Basic | -$2.48B | -$284.5M | |
| Gross Profit | -$6.9M | ||
| Selling And Marketing Expense | $189.5M | ||
| Other Nonoperating Expense | $10.1M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $40.0M | ||
| Income Taxes Paid Net | $1.1M | ||
| General And Administrative Expense | $74.9M | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.45B | ||
| Comprehensive Income Net Of Tax | -$2.45B | ||
| Operating Expenses | $2.24B | $474.5M | |
| Income Tax Expense Benefit | $326.0K | $1.6M | |
| Income Loss From Equity Method Investments | $6.9M | $6.0M | |
| Research And Development Expense | $31.2M | ||
| Amortization Of Intangible Assets | $87.0K | ||
| Other Nonoperating Income | $2.4M | $20.4M | |
| Interest Expense | $29.0M | $24.5M | |
| Net Income Loss Attributable To Noncontrolling Interest | -$5.4M | ||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$717.0M | -$2.03B | -$295.5M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$3.9M | ||
| Net Income Loss From Continuing Operations Available To Common Shareholders Basic | -$2.03B | -$295.1M | |
| Income Loss From Continuing Operations Per Diluted Share | -$2.28 | ||
| Income Loss From Continuing Operations Per Basic Share | -$2.28 | ||
| Income Loss From Continuing Operations | -$2.03B |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$368.0M | -$1.27B | -$1.51B | -$2.00B | -$2.34B | $469.2M | $2.37B | -$8.13B | -$4.44B | -$2.56B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.5M | $93.3M | $136.3M | $233.7M | $797.4M | $1.19B | $1.81B | $1.73B | $1.04B | $1.11B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$69.4M | -$43.0M | -$97.4M | -$563.7M | -$1.60B | $904.8M | $871.1M | -$778.4M | ||
| Gain Loss On Sale Of Property Plant Equipment | -$512.0K | -$670.0K | $1.5M | -$6.6M | -$2.7M | -$290.0K | -$1.5M | -$5.5M | ||
| Cash And Cash Equivalents At Carrying Value | $3.4M | $92.7M | $128.0M | $192.6M | $342.5M | $478.2M | $801.0M | $292.0M | ||
| Common Stock Value | $39.8M | $806.0K | $782.0K | $733.0K | $581.0K | $581.0K | $575.0K | $30.0K | ||
| Assets | $1.95B | $718.6M | $1.25B | $1.23B | $2.65B | $5.38B | $7.35B | $5.30B | ||
| Allowance For Doubtful Other Receivables Current | $21.1M | $26.5M | $30.3M | $21.0M | $51.7M | $6.1M | $6.5M | $272.0K | $269.0K | |
| Retained Earnings Accumulated Deficit | -$2.68B | -$16.95B | -$16.05B | -$15.91B | -$15.49B | -$12.67B | -$10.68B | -$8.21B | ||
| Restricted Cash Current | $105.0K | $618.0K | $8.3M | $41.1M | $454.9M | $707.0M | $1.01B | $1.62B | ||
| Property Plant And Equipment Net | $9.8M | $63.7M | $34.5M | $29.3M | $87.6M | $110.1M | $199.3M | $156.6M | ||
| Prepaid Expense And Other Assets Current | $11.9M | $61.4M | $90.0M | $107.8M | $137.1M | $158.9M | $417.3M | $249.8M | ||
| Other Receivables Net Current | $2.1M | $15.3M | $166.0M | $110.0M | $287.8M | $440.1M | $707.4M | $251.6M | ||
| Minority Interest | -$239.0K | -$175.0K | -$163.0K | -$163.0K | -$154.0K | -$4.0M | -$2.5M | -$50.5M | ||
| Liabilities Noncurrent | $1.40B | $692.5M | $936.2M | $2.08B | $1.92B | $1.92B | $505.9M | $719.6M | ||
| Liabilities Current | $762.0M | $603.9M | $1.30B | $1.15B | $3.08B | $2.99B | $4.47B | $4.34B | ||
| Liabilities And Stockholders Equity | $267.4M | $718.6M | $1.25B | $1.23B | $2.65B | $5.38B | $7.35B | $5.30B | ||
| Liabilities | $2.17B | $1.30B | $2.23B | $3.23B | $4.99B | $4.92B | $4.98B | $5.06B | ||
| Inventory Net | $207.4M | $110.9M | $426.3M | $69.6M | $10.3M | $13.8M | $19.4M | $77.9M | ||
| Assets Noncurrent | $220.9M | $436.9M | $376.9M | $400.6M | $408.5M | $438.2M | $680.8M | $396.0M | ||
| Assets Current | $46.5M | $281.7M | $874.3M | $832.9M | $2.24B | $4.94B | $6.67B | $4.90B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $31.2M | $220.2M | $288.5M | $217.7M | $106.8M | $68.2M | $86.1M | $76.6M | ||
| Accrued Liabilities Current | $306.4M | $336.8M | $674.3M | $894.6M | $1.18B | $1.30B | $1.13B | $927.4M | ||
| Accounts Receivable Net Current | $4.2M | $790.0K | $832.0K | $2.4M | $6.4M | $44.6M | $51.6M | $40.2M | ||
| Accounts Payable Current | $81.6M | $80.7M | $92.5M | $101.2M | $132.4M | $127.8M | $156.3M | $65.7M | ||
| Additional Paid In Capital Common Stock | $2.60B | $15.45B | $14.25B | $13.70B | $13.04B | $13.07B | $12.97B | |||
| Operating Lease Right Of Use Asset | $26.6M | $84.5M | $29.6M | $46.8M | $34.5M | $45.4M | ||||
| Operating Lease Liability Noncurrent | $180.9M | $77.5M | $10.9M | $34.4M | $1.9M | $10.1M | ||||
| Long Term Investments | $279.3M | $288.7M | $288.8M | $288.4M | $276.8M | $272.9M | $349.9M | $40.6M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $28.6M | $17.5M | $15.4M | $11.0M | $75.9M | |||||
| Inventory Write Down | $9.3M | -$12.0M | $14.2M | $16.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2020 | Q1 2019 |
|---|---|---|
| Stockholders Equity * | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$412.8M | $333.8M |
| Gain Loss On Sale Of Property Plant Equipment | -$1.2M | |
| Cash And Cash Equivalents At Carrying Value | ||
| Common Stock Value | ||
| Assets | ||
| Allowance For Doubtful Other Receivables Current | ||
| Retained Earnings Accumulated Deficit | ||
| Restricted Cash Current | ||
| Property Plant And Equipment Net | ||
| Prepaid Expense And Other Assets Current | ||
| Other Receivables Net Current | ||
| Minority Interest | ||
| Liabilities Noncurrent | ||
| Liabilities Current | ||
| Liabilities And Stockholders Equity | ||
| Liabilities | ||
| Inventory Net | ||
| Assets Noncurrent | ||
| Assets Current | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | ||
| Accrued Liabilities Current | ||
| Accounts Receivable Net Current | ||
| Accounts Payable Current | ||
| Additional Paid In Capital Common Stock | ||
| Operating Lease Right Of Use Asset | ||
| Operating Lease Liability Noncurrent | ||
| Long Term Investments | ||
| Operating Lease Right Of Use Asset Amortization Expense | $1.3M | |
| Inventory Write Down |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$262.4M | -$251.1M | -$845.0M | -$1.12B | -$1.19B | -$2.28B | -$1.83B | -$661.2M |
| Net Cash Provided By Used In Investing Activities | -$11.3M | -$32.0M | -$16.8M | $443.0M | -$484.3M | -$1.08B | -$586.8M | $9.3M |
| Net Cash Provided By Used In Financing Activities | $205.3M | $240.0M | $764.4M | $130.3M | $73.6M | $4.27B | $3.29B | -$133.0M |
| Share Based Compensation | $75.8M | $47.3M | $26.5M | -$19.1M | $100.3M | $1.05B | $165.9M | $226.4M |
| Payments To Acquire Property Plant And Equipment | $12.7M | $33.2M | $18.7M | $413.0K | $46.8M | $133.9M | $81.2M | $94.9M |
| Increase Decrease In Receivables Prepaid Expense And Other Assets | $15.3M | -$28.3M | -$51.8M | -$48.3M | -$315.7M | $595.3M | $222.4M | $59.0M |
| Increase Decrease In Loan Recognized As Result Of Payment Under Guarantee Net Current | -$2.3M | -$14.3M | -$148.7M | -$134.4M | $1.53B | $409.1M | $478.5M | $14.4M |
| Increase Decrease In Inventories | $11.6M | -$327.1M | $372.1M | $75.6M | -$5.6M | -$58.6M | $67.3M | $4.3M |
| Increase Decrease In Contract With Customer Liability | $495.0K | -$4.1M | -$5.2M | -$27.1M | -$60.9M | -$87.6M | $6.5M | $10.8M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $33.0M | -$204.8M | -$266.9M | -$354.7M | $679.3M | $654.3M | $911.6M | $170.2M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$914.0K | $221.0K | -$113.0K | -$14.7M | $960.0K | -$9.3M | $3.3M | $6.5M |
| Proceeds From Sale Of Property Plant And Equipment | $1.4M | $494.0K | $1.9M | $13.4M | $43.6M | $7.7M | $885.0K | $11.5M |
| Proceeds From Stock Options Exercised | $4.0K | $42.0K | $15.7M | $1.9M | $12.9M | |||
| Increase Decrease In Leasing Receivables | -$10.0K | -$8.5M | -$156.3M | -$141.5M | $26.8M | $347.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2020 | Q1 2019 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$411.3M | $188.1M |
| Net Cash Provided By Used In Investing Activities | $159.9M | $6.6M |
| Net Cash Provided By Used In Financing Activities | -$165.5M | $127.1M |
| Share Based Compensation | -$32.6M | |
| Payments To Acquire Property Plant And Equipment | $307.0K | |
| Increase Decrease In Receivables Prepaid Expense And Other Assets | -$138.6M | |
| Increase Decrease In Loan Recognized As Result Of Payment Under Guarantee Net Current | $251.2M | |
| Increase Decrease In Inventories | -$3.5M | |
| Increase Decrease In Contract With Customer Liability | -$3.9M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$101.8M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.1M | $12.0M |
| Proceeds From Sale Of Property Plant And Equipment | $451.0K | |
| Proceeds From Stock Options Exercised | $629.0K | |
| Increase Decrease In Leasing Receivables | -$102.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-1.11 | $-0.66 | $-2.07 | $-4.99 | $-76.51 | $-36.11 |
| Earnings Per Share Basic | $-1.11 | $-0.66 | $-0.12 | $-0.73 | $-76.51 | $-36.11 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $1.5M | -$2.5M | -$9.3M | -$15.9M | $4.2M | -$8.2M | -$627.0K | $1.9M |
| Depreciation | $12.3M | $13.4M | $14.3M | $46.4M | $88.9M | $88.8M | $68.2M | $49.3M |
| Investment Income Interest | $169.0K | $603.0K | $3.7M | $45.1M | $15.0M | $24.6M | $2.2M | |
| Interest Paid Net | $2.6M | $58.9M | $5.1M | $19.7M | $77.9M | $32.1M | $6.4M | $3.5M |
| Operating Income Other | $18.0M | $70.0M | $82.0M | $246.3M | $1.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2020 | Q1 2019 |
|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | -$388.0K | -$779.0K |
| Depreciation | $21.3M | |
| Investment Income Interest | $3.1M | |
| Interest Paid Net | ||
| Operating Income Other | $56.0M |
Most recent annual filing with the SEC: April 30, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.